Index NDX, S&P 500
P/E -
EPS (ttm) -12.41
Insider Own 12.19%
Shs Outstand 382.00M
Perf Week 2.37%
Market Cap 40.80B
Forward P/E -
EPS next Y -5.21
Insider Trans -0.49%
Shs Float 336.22M
Perf Month 9.31%
Income -4714.00M
PEG -
EPS next Q -3.45
Inst Own 65.84%
Short Float 6.61%
Perf Quarter 5.79%
Sales 6.86B
P/S 5.95
EPS this Y 41.66%
Inst Trans 0.90%
Short Ratio 5.01
Perf Half Y 7.16%
Book/sh 36.27
P/B 2.94
EPS next Y 27.60%
ROA -21.18%
Short Interest 22.23M
Perf Year -27.47%
Cash/sh 22.52
P/C 4.73
EPS next 5Y -
ROE -28.59%
52W Range 62.55 - 163.24
Perf YTD 7.15%
Dividend Est. -
P/FCF -
EPS past 5Y -20.02%
ROI -31.28%
52W High -34.72%
Beta 1.62
Dividend TTM -
Quick Ratio 3.36
Sales past 5Y 827.00%
Gross Margin 22.52%
52W Low 70.36%
ATR (14) 4.84
Dividend Ex-Date -
Current Ratio 3.42
EPS Y/Y TTM -158.58%
Oper. Margin -61.71%
RSI (14) 55.19
Volatility 4.60% 4.56%
Employees 5600
Debt/Eq 0.09
Sales Y/Y TTM -64.12%
Profit Margin -68.76%
Recom 2.27
Target Price 129.46
Option/Short Yes / Yes
LT Debt/Eq 0.09
EPS Q/Q -84.81%
Payout 0.00%
Rel Volume 0.89
Prev Close 110.59
Sales Surprise 11.94%
EPS Surprise 155.74%
Sales Q/Q -44.05%
Earnings Feb 22 BMO
Avg Volume 4.44M
Price 106.56
SMA20 3.15%
SMA50 7.61%
SMA200 6.05%
Trades
Volume 3,955,885
Change -3.64%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Downgrade
HSBC Securities
Hold → Reduce
$75 → $86
Jan-02-24 Upgrade
Oppenheimer
Perform → Outperform
$142
Nov-29-23 Initiated
Canaccord Genuity
Hold
$82
Nov-03-23 Upgrade
HSBC Securities
Reduce → Hold
$89 → $69
Nov-02-23 Downgrade
Deutsche Bank
Hold → Sell
$125 → $60
Aug-04-23 Downgrade
TD Cowen
Outperform → Market Perform
$145 → $125
Aug-03-23 Downgrade
Deutsche Bank
Buy → Hold
$125
Jul-24-23 Initiated
William Blair
Mkt Perform
$136.28
Jul-14-23 Initiated
HSBC Securities
Reduce
$97
Jun-26-23 Upgrade
UBS
Neutral → Buy
$221 → $191
Apr-26-23 Initiated
Guggenheim
Neutral
Mar-13-23 Upgrade
TD Cowen
Market Perform → Outperform
$150 → $180
Mar-02-23 Initiated
RBC Capital Mkts
Outperform
$200
Feb-24-23 Downgrade
SVB Securities
Market Perform → Underperform
$111 → $93
Dec-19-22 Upgrade
Jefferies
Hold → Buy
$170 → $275
Dec-14-22 Downgrade
Chardan Capital Markets
Buy → Neutral
$186 → $191
Oct-21-22 Upgrade
SVB Leerink
Underperform → Mkt Perform
$174 → $101
Sep-08-22 Upgrade
Deutsche Bank
Hold → Buy
$165
Feb-01-22 Upgrade
Redburn
Sell → Neutral
Jan-26-22 Upgrade
Deutsche Bank
Sell → Hold
$175
Show Previous Ratings
Today 04:49PM
11:38AM
05:55AM
Mar-27-24 03:22PM
(Investor's Business Daily)
02:36PM
02:13PM
Loading…
02:13PM
01:21PM
12:24PM
11:01AM
10:46AM
09:53AM
09:33AM
08:50AM
08:50AM
08:19AM
08:15AM
Loading…
08:15AM
07:55AM
06:59AM
06:51AM
06:34AM
06:30AM
06:30AM
Mar-26-24 02:15PM
01:51PM
10:33AM
09:50AM
08:13AM
07:00AM
Mar-23-24 05:50AM
03:46AM
08:03PM
Loading…
Mar-21-24 08:03PM
11:38AM
09:17AM
04:39AM
Mar-20-24 02:11PM
(Investor's Business Daily)
Mar-19-24 08:30AM
Mar-18-24 05:50PM
08:11AM
06:50AM
Mar-17-24 05:20PM
Mar-15-24 12:39PM
10:36AM
Mar-13-24 09:24AM
07:07AM
06:12AM
Mar-12-24 05:50PM
12:06PM
08:30AM
08:03AM
08:00AM
Mar-11-24 05:10PM
04:53PM
04:24PM
(Investor's Business Daily)
03:29PM
(The Wall Street Journal)
08:53AM
Mar-09-24 01:09PM
Mar-08-24 05:04PM
10:10AM
Mar-07-24 12:07PM
(Investor's Business Daily)
Mar-06-24 06:30AM
(The Wall Street Journal)
Mar-05-24 01:05PM
09:20AM
Mar-04-24 08:28PM
11:02AM
Mar-03-24 01:17PM
05:45AM
Mar-02-24 01:10PM
10:42AM
09:30AM
08:45AM
Mar-01-24 07:00AM
Feb-29-24 04:49PM
07:00AM
05:50AM
Feb-28-24 07:00AM
06:38AM
Feb-27-24 11:43AM
Feb-26-24 02:43PM
11:17AM
09:34AM
08:58AM
07:42AM
05:51AM
Feb-23-24 12:31PM
12:21PM
04:22AM
(The Wall Street Journal)
02:49AM
Feb-22-24 10:40PM
(Thomson Reuters StreetEvents) +13.53%
04:10PM
(Investor's Business Daily)
02:36PM
02:21PM
01:39PM
01:29PM
01:08PM
12:43PM
12:30PM
12:21PM
11:42AM
11:24AM
11:22AM
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
AFEYAN NOUBAR Director Mar 20 '24 Sale 102.39 15,000 1,535,820 2,116,931 Mar 22 07:00 PM Hoge Stephen President Mar 15 '24 Sale 103.17 15,000 1,547,550 1,501,241 Mar 19 04:39 PM AFEYAN NOUBAR Director Mar 13 '24 Sale 108.54 15,000 1,628,031 2,131,931 Mar 15 07:00 PM Klinger Shannon Thyme Chief Legal Officer Mar 08 '24 Sale 99.05 544 53,884 9,267 Mar 11 09:05 AM Hoge Stephen President Mar 04 '24 Sale 94.34 309 29,151 1,516,241 Mar 05 05:52 PM Klinger Shannon Thyme Chief Legal Officer Mar 04 '24 Sale 94.34 117 11,038 8,673 Mar 05 05:56 PM Hoge Stephen President Feb 29 '24 Sale 94.57 2,388 225,838 1,515,898 Mar 01 05:25 PM Klinger Shannon Thyme Chief Legal Officer Feb 29 '24 Sale 94.57 670 63,363 8,557 Mar 01 05:29 PM Mock James M Chief Financial Officer Feb 29 '24 Sale 94.57 647 61,188 4,300 Mar 01 05:33 PM Hoge Stephen President Feb 22 '24 Sale 100.00 15,000 1,500,000 1,513,433 Feb 23 04:04 PM Bancel Stephane Chief Executive Officer Feb 16 '24 Sale 88.88 26,351 2,342,098 5,460,224 Feb 16 04:10 PM Hoge Stephen President Feb 16 '24 Sale 88.88 10,542 936,981 1,528,433 Feb 16 04:19 PM Hoge Stephen President Feb 12 '24 Sale 86.23 304 26,214 1,516,281 Feb 13 04:13 PM Hoge Stephen President Jan 16 '24 Sale 103.90 15,000 1,558,500 1,516,063 Jan 17 04:12 PM Mock James M Chief Financial Officer Jan 08 '24 Sale 109.75 772 84,731 3,632 Jan 09 04:08 PM Hoge Stephen President Dec 27 '23 Sale 100.01 45,000 4,500,450 1,531,063 Dec 28 08:00 AM Klinger Shannon Thyme Chief Legal Officer Dec 08 '23 Sale 79.09 563 44,525 7,912 Dec 11 04:03 PM Garay Arpa Chief Commercial Officer Dec 06 '23 Sale 78.34 564 44,182 3,690 Dec 07 04:21 PM Hoge Stephen President Dec 04 '23 Sale 79.31 309 24,508 1,576,063 Dec 05 04:07 PM Klinger Shannon Thyme Chief Legal Officer Dec 04 '23 Sale 79.31 111 8,804 7,336 Dec 05 04:10 PM Hoge Stephen President Nov 29 '23 Sale 79.81 1,136 90,666 1,575,721 Nov 30 04:11 PM Hoge Stephen President Nov 10 '23 Sale 68.76 263 18,084 1,574,446 Nov 13 04:02 PM AFEYAN NOUBAR Director Nov 01 '23 Sale 76.00 10,000 760,032 2,146,931 Nov 03 07:00 PM AFEYAN NOUBAR Director Oct 25 '23 Sale 76.99 10,000 769,854 2,156,931 Oct 27 07:00 PM AFEYAN NOUBAR Director Oct 11 '23 Sale 103.30 15,000 1,549,441 2,166,931 Oct 13 07:00 PM Mock James M Chief Financial Officer Oct 06 '23 Sale 102.50 2,858 292,953 2,952 Oct 10 04:51 PM AFEYAN NOUBAR Director Oct 04 '23 Sale 102.72 15,000 1,540,845 2,181,931 Oct 06 07:02 PM AFEYAN NOUBAR Director Sep 27 '23 Sale 98.96 10,000 989,646 2,196,931 Sep 29 07:00 PM AFEYAN NOUBAR Director Sep 20 '23 Sale 104.74 15,000 1,571,090 2,206,931 Sep 22 07:00 PM Hoge Stephen President Sep 15 '23 Sale 112.99 15,000 1,694,850 1,574,187 Sep 18 04:06 PM AFEYAN NOUBAR Director Sep 13 '23 Sale 109.70 15,000 1,645,522 2,221,931 Sep 15 07:00 PM Klinger Shannon Thyme Chief Legal Officer Sep 08 '23 Sale 107.22 557 59,722 7,215 Sep 11 04:02 PM AFEYAN NOUBAR Director Sep 06 '23 Sale 107.61 15,000 1,614,094 1,982,209 Sep 08 07:01 PM Garay Arpa Chief Commercial Officer Sep 06 '23 Sale 108.40 574 62,219 3,113 Sep 07 04:46 PM Hoge Stephen President Sep 05 '23 Sale 111.44 320 35,660 1,589,187 Sep 06 04:08 PM Klinger Shannon Thyme Chief Legal Officer Sep 05 '23 Sale 111.44 115 12,815 6,634 Sep 06 04:17 PM AFEYAN NOUBAR Director Aug 30 '23 Sale 115.46 15,000 1,731,951 1,997,209 Sep 01 07:00 PM Hoge Stephen President Aug 29 '23 Sale 115.01 1,135 130,542 1,588,855 Aug 30 04:07 PM AFEYAN NOUBAR Director Aug 23 '23 Sale 115.51 15,000 1,732,613 2,012,209 Aug 25 07:00 PM Hoge Stephen President Aug 17 '23 Sale 100.00 15,000 1,500,000 1,587,579 Aug 18 05:16 PM AFEYAN NOUBAR Director Aug 16 '23 Sale 97.56 10,000 975,614 2,027,209 Aug 18 07:01 PM Hoge Stephen President Aug 10 '23 Sale 102.53 247 25,325 1,602,579 Aug 11 04:18 PM AFEYAN NOUBAR Director Aug 02 '23 Sale 110.99 15,000 1,664,876 2,037,209 Aug 04 07:00 PM AFEYAN NOUBAR Director Jul 26 '23 Sale 120.42 15,000 1,806,229 2,052,209 Jul 28 07:05 PM AFEYAN NOUBAR Director Jul 19 '23 Sale 125.48 15,000 1,882,152 2,067,209 Jul 21 07:00 PM Hoge Stephen President Jul 17 '23 Sale 120.60 15,000 1,809,000 1,602,303 Jul 18 04:35 PM AFEYAN NOUBAR Director Jul 12 '23 Sale 125.81 15,000 1,887,081 2,082,209 Jul 14 07:01 PM AFEYAN NOUBAR Director Jul 05 '23 Sale 124.73 15,000 1,870,933 2,097,209 Jul 07 07:00 PM Bancel Stephane Chief Executive Officer Jun 28 '23 Option Exercise 0.99 27,155 26,883 5,439,101 Jun 30 04:51 PM Bancel Stephane Chief Executive Officer Jun 28 '23 Sale 121.63 27,155 3,302,907 5,411,946 Jun 30 04:51 PM AFEYAN NOUBAR Director Jun 28 '23 Sale 121.54 15,000 1,823,160 2,112,209 Jun 30 07:02 PM Bancel Stephane Chief Executive Officer Jun 22 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 23 04:03 PM Bancel Stephane Chief Executive Officer Jun 22 '23 Sale 119.41 40,000 4,776,427 5,411,946 Jun 23 04:03 PM Bancel Stephane Chief Executive Officer Jun 21 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 23 04:03 PM Bancel Stephane Chief Executive Officer Jun 21 '23 Sale 121.98 40,000 4,879,287 5,411,946 Jun 23 04:03 PM AFEYAN NOUBAR Director Jun 21 '23 Sale 121.95 15,000 1,829,227 2,127,209 Jun 23 07:01 PM Bancel Stephane Chief Executive Officer Jun 15 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 16 04:15 PM Bancel Stephane Chief Executive Officer Jun 15 '23 Sale 128.41 40,000 5,136,388 5,411,946 Jun 16 04:15 PM Hoge Stephen President Jun 15 '23 Sale 125.93 15,000 1,888,950 1,617,303 Jun 16 04:10 PM Bancel Stephane Chief Executive Officer Jun 14 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 16 04:15 PM Bancel Stephane Chief Executive Officer Jun 14 '23 Sale 126.14 40,000 5,045,486 5,411,946 Jun 16 04:15 PM AFEYAN NOUBAR Director Jun 14 '23 Sale 126.18 15,000 1,892,627 2,142,209 Jun 16 07:00 PM Bancel Stephane Chief Executive Officer Jun 08 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 09 04:14 PM Bancel Stephane Chief Executive Officer Jun 08 '23 Sale 124.01 40,000 4,960,364 5,411,946 Jun 09 04:14 PM Klinger Shannon Thyme Chief Legal Officer Jun 08 '23 Sale 124.09 565 70,111 6,516 Jun 09 04:09 PM Bancel Stephane Chief Executive Officer Jun 07 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 09 04:14 PM Bancel Stephane Chief Executive Officer Jun 07 '23 Sale 125.81 40,000 5,032,420 5,411,946 Jun 09 04:14 PM AFEYAN NOUBAR Director Jun 07 '23 Sale 125.91 15,000 1,888,601 2,157,209 Jun 09 07:00 PM Garay Arpa Chief Commercial Officer Jun 06 '23 Sale 125.75 2,290 287,972 2,547 Jun 07 04:05 PM Hoge Stephen President Jun 02 '23 Sale 130.32 309 40,270 1,632,303 Jun 05 04:16 PM Klinger Shannon Thyme Chief Legal Officer Jun 02 '23 Sale 130.32 110 14,336 5,942 Jun 05 04:20 PM Bancel Stephane Chief Executive Officer Jun 01 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 02 04:46 PM Bancel Stephane Chief Executive Officer Jun 01 '23 Sale 127.96 40,000 5,118,473 5,411,946 Jun 02 04:46 PM Bancel Stephane Chief Executive Officer May 31 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 02 04:46 PM Bancel Stephane Chief Executive Officer May 31 '23 Sale 126.91 40,000 5,076,558 5,411,946 Jun 02 04:46 PM AFEYAN NOUBAR Director May 31 '23 Sale 127.35 15,000 1,910,322 2,172,209 Jun 02 07:00 PM Hoge Stephen President May 30 '23 Sale 124.95 1,181 147,569 1,631,961 May 31 04:21 PM Bancel Stephane Chief Executive Officer May 25 '23 Option Exercise 0.99 40,000 39,600 5,451,946 May 26 04:59 PM Bancel Stephane Chief Executive Officer May 25 '23 Sale 127.36 40,000 5,094,421 5,411,946 May 26 04:59 PM Bancel Stephane Chief Executive Officer May 24 '23 Option Exercise 0.99 40,000 39,600 5,451,946 May 26 04:59 PM Bancel Stephane Chief Executive Officer May 24 '23 Sale 131.43 40,000 5,257,212 5,411,946 May 26 04:59 PM Bancel Stephane Chief Executive Officer May 18 '23 Option Exercise 0.99 40,000 39,600 5,451,946 May 19 04:12 PM Bancel Stephane Chief Executive Officer May 18 '23 Sale 123.77 40,000 4,950,999 5,411,946 May 19 04:12 PM Bancel Stephane Chief Executive Officer May 17 '23 Option Exercise 0.99 40,000 39,600 5,451,946 May 19 04:12 PM Bancel Stephane Chief Executive Officer May 17 '23 Sale 125.32 40,000 5,012,648 5,411,946 May 19 04:12 PM Bancel Stephane Chief Executive Officer May 11 '23 Option Exercise 0.99 40,000 39,600 5,451,946 May 12 04:08 PM Bancel Stephane Chief Executive Officer May 11 '23 Sale 127.26 40,000 5,090,486 5,411,946 May 12 04:08 PM Bancel Stephane Chief Executive Officer May 10 '23 Option Exercise 0.99 40,000 39,600 5,451,946 May 12 04:08 PM Bancel Stephane Chief Executive Officer May 10 '23 Sale 131.60 40,000 5,264,032 5,411,946 May 12 04:08 PM Hoge Stephen President May 10 '23 Sale 133.37 250 33,344 1,630,732 May 11 04:09 PM Bancel Stephane Chief Executive Officer May 04 '23 Option Exercise 0.99 40,000 39,600 5,451,946 May 05 04:08 PM Bancel Stephane Chief Executive Officer May 04 '23 Sale 135.70 40,000 5,428,125 5,411,946 May 05 04:08 PM Bancel Stephane Chief Executive Officer May 03 '23 Option Exercise 0.99 40,000 39,600 5,451,946 May 05 04:08 PM Bancel Stephane Chief Executive Officer May 03 '23 Sale 131.29 40,000 5,251,498 5,411,946 May 05 04:08 PM Bancel Stephane Chief Executive Officer Apr 27 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Apr 28 04:51 PM Bancel Stephane Chief Executive Officer Apr 27 '23 Sale 130.61 40,000 5,224,570 5,411,946 Apr 28 04:51 PM Bancel Stephane Chief Executive Officer Apr 26 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Apr 28 04:51 PM Bancel Stephane Chief Executive Officer Apr 26 '23 Sale 131.73 40,000 5,269,140 5,411,946 Apr 28 04:51 PM Bancel Stephane Chief Executive Officer Apr 20 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Apr 21 05:05 PM Bancel Stephane Chief Executive Officer Apr 20 '23 Sale 142.99 40,000 5,719,540 5,411,946 Apr 21 05:05 PM
Index RUT
P/E -
EPS (ttm) -0.77
Insider Own 3.79%
Shs Outstand 32.67M
Perf Week -0.05%
Market Cap 2.42B
Forward P/E 128.80
EPS next Y 0.57
Insider Trans -9.68%
Shs Float 31.48M
Perf Month -9.83%
Income -25.03M
PEG -
EPS next Q -0.02
Inst Own 109.01%
Short Float 17.18%
Perf Quarter -8.19%
Sales 241.62M
P/S 10.01
EPS this Y 95.31%
Inst Trans 21.34%
Short Ratio 8.73
Perf Half Y 29.92%
Book/sh 4.20
P/B 17.61
EPS next Y 1689.57%
ROA -5.09%
Short Interest 5.41M
Perf Year -1.00%
Cash/sh 12.07
P/C 6.13
EPS next 5Y -
ROE -15.42%
52W Range 36.42 - 99.63
Perf YTD -6.32%
Dividend Est. -
P/FCF -
EPS past 5Y 8.36%
ROI -3.84%
52W High -25.79%
Beta 1.98
Dividend TTM -
Quick Ratio 8.49
Sales past 5Y 95.07%
Gross Margin 63.77%
52W Low 103.02%
ATR (14) 4.20
Dividend Ex-Date -
Current Ratio 9.30
EPS Y/Y TTM 38.28%
Oper. Margin -0.63%
RSI (14) 41.18
Volatility 5.00% 5.25%
Employees 584
Debt/Eq 3.76
Sales Y/Y TTM 158.53%
Profit Margin -10.36%
Recom 1.29
Target Price 99.33
Option/Short Yes / Yes
LT Debt/Eq 3.75
EPS Q/Q 156.17%
Payout -
Rel Volume 1.41
Prev Close 74.12
Sales Surprise 18.51%
EPS Surprise 273.41%
Sales Q/Q 158.72%
Earnings Feb 26 AMC
Avg Volume 619.51K
Price 73.94
SMA20 -6.35%
SMA50 -11.15%
SMA200 2.45%
Trades
Volume 876,307
Change -0.24%
Date
Action
Analyst
Rating Change
Price Target Change
Today Initiated
Piper Sandler
Overweight
$95
Jul-19-23 Initiated
Robert W. Baird
Outperform
Aug-02-22 Upgrade
JP Morgan
Neutral → Overweight
$48
Oct-08-20 Downgrade
JP Morgan
Overweight → Neutral
$15
Apr-07-20 Initiated
Oppenheimer
Outperform
$25
May-28-19 Initiated
Morgan Stanley
Equal-Weight
May-28-19 Initiated
JP Morgan
Overweight
May-28-19 Initiated
Cowen
Outperform
May-28-19 Initiated
Canaccord Genuity
Buy
Mar-19-24 04:05PM
Mar-05-24 11:52PM
08:02AM
Mar-03-24 06:23AM
Mar-01-24 08:45AM
04:06PM
Loading…
Feb-28-24 04:06PM
04:05PM
11:00AM
Feb-27-24 05:59PM
08:10AM
(Thomson Reuters StreetEvents)
Feb-26-24 05:38PM
(Associated Press Finance) -6.50%
04:53PM
04:05PM
Feb-18-24 06:37AM
Feb-16-24 04:05PM
04:04PM
Loading…
Feb-15-24 04:04PM
Feb-12-24 04:05PM
05:37AM
Feb-10-24 02:07AM
Feb-02-24 11:02PM
Jan-29-24 03:50PM
Jan-25-24 03:15PM
Jan-22-24 10:30AM
Jan-16-24 04:05PM
Dec-29-23 08:52AM
Dec-27-23 05:50AM
Dec-26-23 01:36PM
Dec-18-23 04:05PM
Dec-12-23 04:05PM
Nov-30-23 05:50AM
05:50AM
Loading…
Nov-25-23 05:50AM
Nov-23-23 05:50AM
Nov-14-23 04:05PM
Nov-12-23 05:50AM
Nov-10-23 09:30AM
05:55AM
Nov-09-23 10:23AM
05:57AM
Nov-07-23 10:16AM
(Thomson Reuters StreetEvents) +51.18%
10:15AM
Nov-06-23 05:19PM
04:42PM
(Associated Press Finance)
04:05PM
01:42PM
Nov-03-23 04:05PM
Nov-01-23 05:45AM
Oct-28-23 05:50AM
Oct-23-23 04:05PM
Oct-20-23 10:15AM
Oct-14-23 05:37AM
Oct-10-23 04:05PM
Oct-05-23 05:01AM
Oct-03-23 08:50AM
Sep-28-23 11:38AM
09:37AM
Sep-13-23 04:23PM
Sep-01-23 06:00PM
Aug-29-23 05:20AM
Aug-28-23 04:05PM
Aug-17-23 11:21AM
Aug-16-23 04:05PM
Aug-12-23 08:07AM
Aug-07-23 04:05PM
Aug-06-23 06:24AM
Aug-05-23 08:32AM
Aug-04-23 03:17PM
Aug-03-23 07:25PM
06:20PM
04:05PM
Aug-02-23 05:28PM
05:00PM
Aug-01-23 11:00AM
Jul-27-23 05:25PM
Jul-26-23 05:09PM
04:05PM
Jul-20-23 04:05PM
Jun-30-23 01:21PM
(Investor's Business Daily)
Jun-29-23 11:16AM
(Investor's Business Daily)
Jun-23-23 02:05PM
(Investor's Business Daily)
Jun-15-23 03:20PM
Jun-10-23 08:00AM
Jun-09-23 02:58PM
(Investor's Business Daily)
Jun-07-23 01:53PM
(Investor's Business Daily)
May-30-23 04:05PM
May-26-23 03:59PM
May-08-23 11:21PM
07:23AM
May-06-23 08:17AM
May-05-23 05:23AM
May-04-23 10:16AM
May-02-23 12:18PM
(Thomson Reuters StreetEvents) -5.18%
May-01-23 05:45PM
04:05PM
08:00AM
Apr-27-23 06:22AM
Apr-26-23 10:01AM
Apr-24-23 10:00AM
04:50AM
Apr-17-23 04:05PM
Apr-06-23 12:48PM
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Khayal Tamer I Chief Commercial Officer Mar 08 '24 Option Exercise 16.14 100 1,614 26,602 Mar 12 07:31 PM Gordon Stephen Chief Financial Officer Mar 08 '24 Sale 87.63 1,903 166,760 23,299 Mar 12 07:28 PM Khayal Tamer I Chief Commercial Officer Mar 08 '24 Sale 87.80 1,417 124,413 25,185 Mar 12 07:31 PM Gordon Stephen Chief Financial Officer Mar 04 '24 Option Exercise 38.46 15,000 576,900 40,202 Mar 05 06:20 PM Gordon Stephen Chief Financial Officer Mar 04 '24 Sale 82.80 15,000 1,242,000 25,202 Mar 05 06:20 PM Khayal Tamer I Chief Commercial Officer Mar 01 '24 Option Exercise 13.28 10,000 132,800 36,502 Mar 05 06:28 PM TOBIN JAMES R Director Mar 01 '24 Sale 83.63 13,380 1,118,955 220,211 Mar 05 06:16 PM Khayal Tamer I Chief Commercial Officer Mar 01 '24 Sale 82.99 10,000 829,892 26,502 Mar 05 06:28 PM Khayal Tamer I Chief Commercial Officer Feb 20 '24 Option Exercise 16.14 250 4,035 14,625 Feb 21 05:01 PM Khayal Tamer I Chief Commercial Officer Feb 20 '24 Sale 90.00 250 22,500 14,375 Feb 21 05:01 PM Khayal Tamer I Chief Commercial Officer Feb 16 '24 Option Exercise 16.08 2,858 45,968 17,233 Feb 21 05:01 PM Khayal Tamer I Chief Commercial Officer Feb 16 '24 Sale 90.00 2,858 257,220 14,375 Feb 21 05:01 PM Khayal Tamer I Chief Commercial Officer Feb 15 '24 Option Exercise 16.00 776 12,416 15,151 Feb 16 05:25 PM Khayal Tamer I Chief Commercial Officer Feb 15 '24 Sale 90.00 776 69,840 14,375 Feb 16 05:25 PM Khayal Tamer I Chief Commercial Officer Feb 14 '24 Option Exercise 16.00 3,050 48,800 17,425 Feb 16 05:25 PM Khayal Tamer I Chief Commercial Officer Feb 14 '24 Sale 90.03 3,050 274,592 14,375 Feb 16 05:25 PM Khayal Tamer I Chief Commercial Officer Feb 07 '24 Option Exercise 16.00 736 11,776 15,111 Feb 09 06:35 PM Khayal Tamer I Chief Commercial Officer Feb 07 '24 Sale 90.09 736 66,306 14,375 Feb 09 06:35 PM Basile Edward M Director Feb 06 '24 Sale 86.38 7,157 618,209 8,350 Feb 08 04:30 PM Gordon Stephen Chief Financial Officer Feb 01 '24 Option Exercise 18.21 15,000 273,151 28,075 Feb 02 06:56 PM Gordon Stephen Chief Financial Officer Feb 01 '24 Sale 85.45 15,000 1,281,750 13,075 Feb 02 06:56 PM Khayal Tamer I Chief Commercial Officer Jan 23 '24 Option Exercise 16.00 2,330 37,280 16,705 Jan 25 04:30 PM Khayal Tamer I Chief Commercial Officer Jan 23 '24 Sale 90.09 2,330 209,910 14,375 Jan 25 04:30 PM Khayal Tamer I Chief Commercial Officer Jan 16 '24 Option Exercise 13.28 10,000 132,800 24,375 Jan 18 04:30 PM Khayal Tamer I Chief Commercial Officer Jan 16 '24 Sale 80.41 10,000 804,088 14,375 Jan 18 04:30 PM Gordon Stephen Chief Financial Officer Jan 02 '24 Option Exercise 13.28 15,000 199,200 28,075 Jan 03 05:00 PM Gordon Stephen Chief Financial Officer Jan 02 '24 Sale 77.07 15,000 1,156,050 13,075 Jan 03 05:00 PM Provost Miriam VP, Global Regulatory Affairs Dec 13 '23 Option Exercise 44.81 5,644 252,914 27,540 Dec 15 05:31 PM Provost Miriam VP, Global Regulatory Affairs Dec 13 '23 Sale 75.10 4,122 309,562 23,820 Dec 15 05:31 PM TOBIN JAMES R Director Nov 28 '23 Sale 70.14 10,000 701,400 233,591 Nov 29 04:38 PM Hassanein Waleed H President & CEO Nov 07 '23 Sale 64.32 15,000 964,800 514,191 Nov 09 07:00 PM Gordon Stephen Chief Financial Officer Oct 02 '23 Option Exercise 16.14 5,000 80,700 23,789 Oct 04 05:00 PM Gordon Stephen Chief Financial Officer Oct 02 '23 Sale 54.22 5,000 271,100 18,789 Oct 04 05:00 PM Hassanein Waleed H President & CEO Sep 01 '23 Sale 68.26 7,500 511,920 529,191 Sep 06 04:31 PM Provost Miriam VP, Global Regulatory Affairs Aug 31 '23 Option Exercise 26.98 5,480 147,857 26,319 Sep 05 04:36 PM Provost Miriam VP, Global Regulatory Affairs Aug 31 '23 Sale 66.52 2,708 180,136 23,611 Sep 05 04:36 PM Weill David Director Aug 29 '23 Buy 62.00 2,500 155,000 13,693 Aug 30 04:33 PM Hassanein Waleed H President & CEO Aug 01 '23 Sale 93.06 7,500 697,929 536,691 Aug 03 08:01 PM Khayal Tamer I Chief Commercial Officer Jul 18 '23 Option Exercise 22.66 5,000 113,310 19,375 Jul 19 06:46 PM Khayal Tamer I Chief Commercial Officer Jul 18 '23 Sale 95.37 5,000 476,850 14,375 Jul 19 06:46 PM Khayal Tamer I Chief Commercial Officer Jul 13 '23 Option Exercise 16.14 2,974 48,000 17,349 Jul 17 04:31 PM Khayal Tamer I Chief Commercial Officer Jul 13 '23 Sale 90.05 2,974 267,809 14,375 Jul 17 04:31 PM Khayal Tamer I Chief Commercial Officer Jul 13 '23 Sale 90.02 2,225 200,294 14,776 Jul 17 04:31 PM Hassanein Waleed H President & CEO Jul 03 '23 Sale 82.51 7,500 618,803 544,191 Jul 06 04:31 PM Hassanein Waleed H President & CEO Jun 01 '23 Sale 71.64 7,500 537,305 551,691 Jun 05 04:34 PM Gordon Stephen Chief Financial Officer May 01 '23 Option Exercise 16.14 5,000 80,700 23,789 May 02 06:31 PM Hassanein Waleed H President & CEO May 01 '23 Sale 78.13 7,500 585,989 559,191 May 02 06:29 PM Gordon Stephen Chief Financial Officer May 01 '23 Sale 79.05 5,000 395,250 18,789 May 02 06:31 PM Khayal Tamer I Chief Commercial Officer Apr 21 '23 Option Exercise 16.14 12,026 194,100 26,401 Apr 25 05:00 PM Khayal Tamer I Chief Commercial Officer Apr 21 '23 Sale 86.28 12,026 1,037,626 14,375 Apr 25 05:00 PM Khayal Tamer I Chief Commercial Officer Apr 21 '23 Sale 90.04 2,775 249,861 17,001 Apr 25 05:00 PM Hassanein Waleed H President & CEO Apr 03 '23 Sale 74.83 7,500 561,196 566,691 Apr 04 05:14 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite